Aug 2026· Advanced Healthcare Materials· Vol 15, pp.
e71645
· 0 citations· 37 references
Medicine
TL;DR
This research develops an NIR-triggered organic photocatalyst that produces hydroxyl radical and photooxidates NADH and achieves antitumor efficacy in 4T1-bearing mouse models, highlighting the potential of employing an NIR-activated organic photocatalyst to integrate phototherapy with hydroxyl radical generation.
Abstract
The development of organic photocatalysts holds considerable promise for the oxidation of NADH, thereby disrupting the NADH/NAD+ equilibrium, modulating redox homeostasis, and enhancing treatment of hypoxic tumors. However, there is still a lack of organic photocatalyst which could respond to near-infrared light. Herein, we develop an NIR-triggered organic photocatalyst (TTH) that produces hydroxyl radical and photooxidates NADH. Upon 808 nm light irradiation, TTH not only could generate hydroxyl radical in an optimized pathway of O2→O2 • -→H2O2→•OH and achieve effective oxidation of NADH and the reduction of cytochrome c, but also produces hyperthermia, facilitating NIR-II fluorescence-guided phototherapy of tumors. Moreover, TTH preferentially degrades glutathione, increases lipid peroxide levels, and downregulates glutathione peroxidase 4, culminating in mitochondrial dysfunction and the initiation of ferroptosis‑like cell death. Subsequently, the in vivo experiments proved that the photocatalytic TTH achieved antitumor efficacy in 4T1-bearing mouse models. Collectively, our research highlights the potential of employing an NIR-activated organic photocatalyst to integrate phototherapy with hydroxyl radical generation, representing a promising therapeutic strategy to disrupt intracellular redox homeostasis for the treatment of tumors.
Peroxynitrite (ONOO-) plays a dominant role in chemistry and biology owing to its dual action as an excellent oxidant and nucleophile. This makes ONOO- a potent cytotoxic agent that can be used as an "unconventional" therapeutic agent, opening new avenues for innovative treatment modalities to tackle a variety of disea...
Cristina Parisi, Samantha Sollima, Francesca Laneri et al.· Journal of materials chemist...· 0 citations
A coordination-driven nanoassembly of ferric-indocyanine green complex in albumin nanocages is reported as an activatable antitumor nanoenzyme for tumor-selective chemodynamic immunotherapy against aggressive cancers.
Ting Li, Xue-Hua Lin, Zhen-Duo Zhao et al.· Journal of Controlled Releas...· 0 citations
Tumor hypoxia, limited solid-tumor imaging, and insufficient systemic antitumor immunity remain major challenges to effective cancer phototheranostics. Here, a molecular conformation engineering strategy is developed to construct TBBP, which features a strengthened electron donor, a moderately twisted conformation, ext...
Xing Wang, Kun-Yan Dong, Zhi-Chao Wang et al.· Advances in Materials· 0 citations
Triple-negative breast cancer (TNBC) treatment is often hindered by tumor hypoxia, cellular survival compensation, and the immuno-suppressive micro-environment. Through the “molecular-electron pumping” strategy, a cyanine photosensitizer BrCy5 with excellent Type I ROS generation ability (two kinds of Type I ROS produc...
Zheng-Bo Li, Guang-Zhao Xu, Fa-Hui Li et al.· Materials Today Bio· 0 citations
Porphyrin derivatives employed for photodynamic therapy (PDT) readily undergo intense π–π stacking, triggering drastic quenching of fluorescence and reactive oxygen species (ROS), which severely restricts their practical utilization in PDT research. In this work, meso-tetrakis(4-carboxyphenyl)porphyrin (TCPP) was ado...
Yuan-Jun Zhang, Guan-Huang Zhang, Yu-Feng Wang et al.· Inorganic Chemistry· 0 citations
To overcome the limitations imposed by hypoxia in photodynamic therapy (PDT), we rationally designed and synthesized three carbonic anhydrase IX (CAIX)-targeted osmium(II) polypyridyl complexes (Os1-Os3) by conjugating a benzenesulfonamide CAIX inhibitor to the photosensitizer core. Among them, Os3 exhibited excellent...
Qin Gong, Xiu-Qin Su, Shan Jiang et al.· Dalton Transactions· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.